MedTrace Logo

Branch Vein Occlusion Study

NCT00000162 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2005-06-24

No results posted yet for this study

Summary

To determine whether scatter argon laser photocoagulation can prevent the development of neovascularization.

To determine whether peripheral scatter argon laser photocoagulation can prevent vitreous hemorrhage.

To determine whether macular argon laser photocoagulation can improve visual acuity in eyes with macular edema reducing vision to 20/40 or worse.

Conditions

  • Macular Degeneration
  • Neovascularization, Pathologic
  • Vitreous Hemorrhage

Interventions

PROCEDURE

Macular Argon Laser Photocoagulation

PROCEDURE

Peripheral Scatter Argon Laser Photocoagulation

PROCEDURE

Scatter Argon Laser Photocoagulation

Sponsors & Collaborators

  • National Eye Institute (NEI)

    lead NIH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1977-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000162 on ClinicalTrials.gov